JP2023525981A5 - - Google Patents
Info
- Publication number
- JP2023525981A5 JP2023525981A5 JP2022566063A JP2022566063A JP2023525981A5 JP 2023525981 A5 JP2023525981 A5 JP 2023525981A5 JP 2022566063 A JP2022566063 A JP 2022566063A JP 2022566063 A JP2022566063 A JP 2022566063A JP 2023525981 A5 JP2023525981 A5 JP 2023525981A5
- Authority
- JP
- Japan
- Prior art keywords
- lung
- dione
- item
- pharmaceutically acceptable
- ethoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382356 | 2020-04-30 | ||
| EP20382356.2 | 2020-04-30 | ||
| PCT/IB2021/053651 WO2021220250A1 (en) | 2020-04-30 | 2021-04-30 | Leriglitazone for treating lung inflammation and interstitial lung disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023525981A JP2023525981A (ja) | 2023-06-20 |
| JP2023525981A5 true JP2023525981A5 (https=) | 2024-05-10 |
Family
ID=70779625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566063A Pending JP2023525981A (ja) | 2020-04-30 | 2021-04-30 | 肺炎症および間質性肺疾患を処置するためのレリグリタゾン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230172921A1 (https=) |
| EP (1) | EP4142720A1 (https=) |
| JP (1) | JP2023525981A (https=) |
| KR (1) | KR20230035522A (https=) |
| CN (1) | CN116390725A (https=) |
| AU (1) | AU2021265345A1 (https=) |
| BR (1) | BR112022021951A2 (https=) |
| CA (1) | CA3180351A1 (https=) |
| IL (1) | IL297771A (https=) |
| MX (1) | MX2022013021A (https=) |
| WO (1) | WO2021220250A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4642456A1 (en) * | 2022-12-28 | 2025-11-05 | Minoryx Therapeutics S.L. | Optimized dosing of leriglitazone |
| WO2024231881A2 (en) * | 2023-05-09 | 2024-11-14 | Minoryx Therapeutics S.L. | Polymorphic forms and formulations of leriglitazone |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ590774A (en) * | 2008-08-07 | 2012-09-28 | Pulmagen Therapeutics Inflammation Ltd | Substantially pure 5R enantiomers of pioglitazone and rosiglitazone for treating inflammatory respiratory diseases |
| WO2010150014A1 (en) * | 2009-06-24 | 2010-12-29 | Pulmagen Therapeutics (Inflammation) Limited | 5r- 5 -deuterated glitazones for respiratory disease treatment |
| WO2011047048A1 (en) * | 2009-10-14 | 2011-04-21 | Gemmus Pharma, Inc. | Combination therapy treatment for viral infections |
| WO2011073662A1 (en) * | 2009-12-17 | 2011-06-23 | Astrazeneca Ab | Combination of a benzoxazinone and a further agent for treating respiratory diseases |
| EA202091120A3 (ru) | 2014-04-02 | 2020-12-30 | Минорикс Терапьютикс С.Л. | Производные 2,4-тиазолинидона в лечении расстройств центральной нервной системы |
| JP7040798B2 (ja) * | 2016-12-01 | 2022-03-23 | ミノリックス セラピューティクス エセ．エレ． | 非アルコール性脂肪性肝疾患を処置するための５－［［４－［２－［５－（１－ヒドロキシエチル）ピリジン－２－イル］エトキシ］フェニル］メチル］－１，３－チアゾリジン－２，４－ジオン |
| CN112823004A (zh) * | 2018-06-06 | 2021-05-18 | 米尼奥尔克斯治疗有限公司 | 5-[[4-[2-[5-乙酰基吡啶-2-基]乙氧基]苄基]-1,3-噻唑烷-2,4-二酮及其盐的用途 |
-
2021
- 2021-04-30 US US17/997,393 patent/US20230172921A1/en not_active Abandoned
- 2021-04-30 EP EP21723015.0A patent/EP4142720A1/en not_active Withdrawn
- 2021-04-30 IL IL297771A patent/IL297771A/en unknown
- 2021-04-30 MX MX2022013021A patent/MX2022013021A/es unknown
- 2021-04-30 CN CN202180043546.3A patent/CN116390725A/zh active Pending
- 2021-04-30 BR BR112022021951A patent/BR112022021951A2/pt unknown
- 2021-04-30 KR KR1020227042096A patent/KR20230035522A/ko not_active Abandoned
- 2021-04-30 AU AU2021265345A patent/AU2021265345A1/en not_active Abandoned
- 2021-04-30 WO PCT/IB2021/053651 patent/WO2021220250A1/en not_active Ceased
- 2021-04-30 CA CA3180351A patent/CA3180351A1/en active Pending
- 2021-04-30 JP JP2022566063A patent/JP2023525981A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024170583A5 (https=) | ||
| JP2004525903A5 (https=) | ||
| JP2008538115A5 (https=) | ||
| JP2009507909A5 (https=) | ||
| JP2023525981A5 (https=) | ||
| JP2023522010A5 (https=) | ||
| JP2005504804A5 (https=) | ||
| JP2014521658A5 (https=) | ||
| AR045289A1 (es) | Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento | |
| JP5470245B2 (ja) | バイオフィルム形成の処置のためのトリアゾール化合物 | |
| JP4627356B2 (ja) | ウイルス性心筋炎の予防または治療薬剤 | |
| JP2023510332A5 (https=) | ||
| JP2010527960A5 (https=) | ||
| JP2017522330A (ja) | ポビドンヨードを使用した感冒の治療および予防 | |
| CN111867582A (zh) | 衣壳组装调节剂给药方案 | |
| CL2024001530A1 (es) | Nuevas combinaciones terapéuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas | |
| JP2009521473A5 (https=) | ||
| JPWO2023054732A5 (https=) | ||
| JP2024164177A (ja) | 疣贅の治療 | |
| JP2005513014A5 (https=) | ||
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| KR20190009294A (ko) | 비강 울혈을 치료/예방하기 위한 카르복실산 | |
| JP2005524666A5 (https=) | ||
| JP2021503448A5 (https=) | ||
| KR20120128644A (ko) | 질환의 치료에 사용하기 위한 화합물 |